3,4-methylenedioxyamphetamine has been researched along with Aortic Valve Insufficiency in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Aortic Valve Insufficiency: Pathological condition characterized by the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to regurgitation. It is caused by diseases of the AORTIC VALVE or its surrounding tissue (aortic root).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tribouilloy, C | 1 |
| Bohbot, Y | 1 |
| Unger, P | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Aortic Valve Insufficiency
| Article | Year |
|---|---|
Mitral Regurgitation in Patients With Severe Aortic Regurgitation: When Misery Loves Company.
Topics: Aortic Valve; Aortic Valve Insufficiency; Heart Valve Prosthesis Implantation; Humans; Love; Mitral | 2020 |